摘要
目的为高血压合并冠状动脉粥样硬化性心脏病(简称冠心病)患者的药物治疗管理(MTM)提供参考。方法药师通过药学问诊、用药评估、方案调整、用药宣教、药学随访等方式,为1例58岁男性高血压合并冠心病患者提供MTM,并建立MTM档案。结果给予MTM前,患者的血压、心率、低密度脂蛋白胆固醇、甘油三酯、尿酸、同型半胱氨酸水平等动脉粥样硬化性心血管疾病(ASCVD)指标分别为>140/90 mmHg、75~80次/分、2.24 mmol/L、4.34 mmol/L、526µmol/L、17.83µmol/L;经过3个月近20次的MTM后,上述指标均改善,分别降为<130/80 mmHg、55~60次/分、1.62 mmol/L、1.39 mmol/L、342µmol/L、8.55µmol/L。结论该例患者接受MTM后的ASCVD各项指标均达标。医院应开设药学门诊,积极为患者提供MTM,提升药学服务能力和临床合理用药水平。
Objective To provide a reference for the medication therapy management(MTM)in patients with hypertension complicated with coronary heart disease(CHD).Methods Pharmacists provided MTM for a 58 year old male patient with hypertension complicated with CHD through pharmacy consultation,medication evaluation,medication plan adjustment,medication education,pharmacy follow-up and establishing the patient's MTM archives.Results Before receiving MTM,the blood pressure,heart rate,low-density lipoprotein cholesterol,triglyceride,uric acid,homocysteine and other indexes of atherosclerotic cardiovascular disease(ASCVD)were>140/90 mmHg,75-80 beats/min,2.24 mmol/L,4.34 mmol/L,526µmol/L,and 17.83µmol/L,respectively.Through nearly 20 times of MTM for three months,the above indexes reduced to<130/80 mmHg,55-60 beats/min,1.62 mmol/L,1.39 mmol/L,and 342µmol/L,and 8.55µmol/L,respectively.Conclusion After receiving MTM,all ASCVD indexes of this patient reached the standard.The hospital should develop pharmacy clinic,actively provide MTM for patients,improve the pharmaceutical care capacity and the level of rational drug use in the clinic.
作者
赵群
孙喜梅
司继刚
杨立莉
ZHAO Qun;SUN Ximei;SI Jigang;YANG Lili(Central Hospital of Zibo City,Zibo,Shandong,China 255036)
出处
《中国药业》
CAS
2024年第9期149-152,共4页
China Pharmaceuticals
基金
山东省淄博市重点研发计划政策引导类项目[2020ZC010112]。
